Europe/European Union - Page 2

AI governance among top data law trends shaping business strategies, study shows

New Freshfields report outlines key data law changes that companies must adapt to

  • 3mos

European Law Institute calls for ‘light-touch’ litigation funding regulation

Excessive regulation could lead to funders exiting the market, potentially reducing access to justice, ELI study suggests

  • 3mos

Co-founder of Powell Gilbert joins Morgan Lewis

Arrival of Tim Powell continues US firm’s European IP push

  • 4mos

Economic concerns, AI top list of European employer concerns, study finds

Littler survey of in-house counsel and other executives also highlights concerns around politics and ESG

  • 4mos

European patent law trends in the life sciences

Decisions from the European Patent Office and more recently the Unitary Patent Court continue to develop patent law affecting the life sciences in Europe, writes Mewburn Ellis patent lawyer Nick Sutcliffe

  • 4mos

IBA endorses first international treaty on AI governance

Support for European convention on AI builds on IBA’s AI report launched at annual conference in Mexico City last month

  • 4mos

Celltrion avoids injunction at UPC in row over asthma drug

Novartis and Genentech had accused Korean rival of “imminent infringement” through marketing of biosimilar

  • 5mos

Mathys & Squire granted access to documents in UPC transparency test case

The way the request was processed still raises ‘significant concerns’, says the firm

  • 5mos

UPC revokes Amgen patent in cholesterol drug battle with Sanofi and Regeneron

Pan-European patent court delivers first revocation judgment a year and a month after opening

  • 7mos

Unified Patent court invalidates Dexcom diabetes patent

Glucose monitoring patent revoked across 17 UPC member states in ongoing dispute with rival Abbott

  • 7mos

Will changes to proposed EU medicinal directive shift the balance towards generics and are they TRIPS compliant?

Mathys & Squire patent litigator Stephen Garner discusses changes to EU pharmaceutical legislation and the impact on IP rights

  • 7mos

UK ratifies Hague-19 Convention in a boost to London litigation

Treaty ensures UK judgments will be recognised in EU and other member countries

  • 7mos

Digital giants beware, EC’s competition enforcer tells young European lawyers

Ben Rigby reports from the European Young Bar Association’s summer conference in Copenhagen

  • 7mos

UPC one year on: a review of the court’s first 12 months in action

Herbert Smith Freehills lawyers Sebastian Moore, Frederic Chevallier and Rachel Montagnon look back on the Unified Patent Court’s maiden year

  • 8mos

Complex global M&A deals face increased merger clearance challenges, study finds

Some 43% of cross-border transactions over the past four years failed to close due to regulatory scrutiny

  • 8mos

Navigating public access to UPC court documents

Balancing confidentiality and transparency is an evolving landscape for UPC proceedings, writes Mewburn Ellis partner Matthew Naylor

  • 8mos

Lawyers react to EU digital markets probe into Apple, Alphabet and Meta

Investigations stem from the EU’s new Digital Markets Act, introduced to curb dominance of tech giants

  • 10mos

Amazon seizes seven million counterfeit products in 2023

E-commerce giant’s report shows number of fake products jumped by a million, as it increasingly leans on AI to detect fakes

  • 10mos

Rihanna puts her foot in it over design rights on Instagram

Puma loses bid to dismiss a design invalidity ruling at the EU's General Court as popstar had already publicly disclosed it

  • 11mos
Top